United Therapeutics Corp at Oppenheimer Fall Healthcare Life Sciences & MedTech Summit (Virtual) Transcript
Thank you, David, for introducing us. And we were already having a pretty good conversation with Martine and I. We are really happy to again have Martine Rothblatt, Dr. Rothblatt, with us today on our OpCo Health Care Conference to provide us an update with United Therapeutics. We also have Dewey Steadman here, who will give us a quick intro, and then we can get the conversation started.
Yes. Good morning. Our remarks today may include forward-looking information about our business, and please see our SEC filings for risks and uncertainties that could cause actual results to differ. And thank you. So I'll turn it back over to you, Hartaj.
Thank you, Dewey. And you are very lucky, I didn't take my morning pot cookie with that background. I'm just kidding, I'm just kidding. That would definitely throw
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |